In addition to the diverse subcellular roles of AMPK signaling discussed previously, characterizing the tissue-specific roles of AMPK signaling is also heavily pursued as it relates to treating cardiovascular disease, liver disease, and other diseases with apparent tissue-specific metabolic origins [157,158]. Here, PRKAA2 is linked to cardiovascular disorder.